Trial Profile
Comparison of ferumoxytol with intravenous iron sucrose/ferric gluconate in patients with end-stage renal disease (ESRD) initiating hemodialysis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 13 Oct 2015
Price :
$35
*
At a glance
- Drugs Ferumoxytol (Primary)
- Indications Renal failure
- Focus Adverse reactions
- 13 Oct 2015 New trial record
- 26 Aug 2015 Results presented at the 31st International Conference on Pharmacoepidemiology and Therapeutic Risk Management.